Choongwe's new bio drug for stroke using stem cells on phase III study.

Choongwe exchanged a memorandum of understanding with FCB Pharmaicell FCBP) on June 30 jointly to develope a new drug for the treatment of stroke using stem cells, for which FCBP obtained an IND from the KFDA for its phase III clinical study. The Memorandum describes a joint development plan between two parties including the condition of which Choongwe has an option right to negotiate with FCBP...